Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-05, Stock:LLY, The news for the past five days is as follows:
2019-06-27: NEWS1: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.NEWS2: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.NEWS3: 3 Big Stock Charts for Thursday: H & R Block, Boeing and Eli Lilly.NEWS4: 3 Big Stock Charts for Thursday: H & R Block, Boeing and Eli Lilly.NEWS5: XLV, AMGN, LLY, SYK: ETF Outflow Alert.NEWS6: XLV, AMGN, LLY, SYK: ETF Outflow Alert.NEWS7: Lilly's Study on Higher Doses of Trulicity Meets Endpoint.
2019-06-28: NEWS1: How Eli Lilly’s EPS and Expenses Are Trending.NEWS2: How Is Eli Lilly’s Revenue Trending in 2019?.NEWS3: What Analysts Recommend for LLY and AMGN.NEWS4: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS5: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.NEWS6: Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger.
2019-07-01: NEWS1: Pain and Immunology: Eli Lilly’s Key Growth Areas.NEWS2: Market Morning: OPEC Cuts, Trump & Xi Ceasefire, Apple Goes to China, Deutsche Bank Hiring.
2019-07-02: NEWS1: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS2: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS3: Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis.NEWS4: 13 Blue-Chip Stocks With Risks You Need to Watch.NEWS5: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS6: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS7: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.
2019-07-03: NEWS1: After Hours Most Active for Jul 3, 2019 :  ZNGA, CTL, KPTI, CSCO, S, MRVL, CVET, PSTG, QQQ, LLY, ESV, KOS.NEWS2: After Hours Most Active for Jul 3, 2019 :  ZNGA, CTL, KPTI, CSCO, S, MRVL, CVET, PSTG, QQQ, LLY, ESV, KOS.NEWS3: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS4: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS5: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS6: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS7: Will the Pharma Space Witness More Mega-Merger Deals in 2H?.NEWS8: Will the Pharma Space Witness More Mega-Merger Deals in 2H?.NEWS9: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS10: Will the Pharma Space Witness More Mega-Merger Deals in 2H?.NEWS11: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS12: Is Eli Lilly and Company (NYSE:LLY) A Good Dividend Stock?.

Answer: Decrease